123 related articles for article (PubMed ID: 12544765)
1. Screening for neuroblastoma: the final chapters.
Woods WG
J Pediatr Hematol Oncol; 2003 Jan; 25(1):3-4. PubMed ID: 12544765
[No Abstract] [Full Text] [Related]
2. False-positive results in neuroblastoma screening: the parents' view.
Dobrovoljski G; Kerbl R; Strobl C; Schwinger W; Dornbusch HJ; Lackner H
J Pediatr Hematol Oncol; 2003 Jan; 25(1):14-8. PubMed ID: 12544768
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
Kerbl R; Urban CE; Ambros IM; Dornbusch HJ; Schwinger W; Lackner H; Ladenstein R; Strenger V; Gadner H; Ambros PF
J Clin Oncol; 2003 Nov; 21(22):4228-34. PubMed ID: 14615452
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
Schilling FH; Oberrauch W; Schanz F; Treuner J
Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
[No Abstract] [Full Text] [Related]
5. Persistence and possible progression of a pelvic neuroblastoma detected by mass screening during 19 months.
Bernstein ML; Azouz EM; Woods W; Tuchman M; Renaud L; Lemieux B
Am J Pediatr Hematol Oncol; 1994 May; 16(2):164-6. PubMed ID: 8166370
[TBL] [Abstract][Full Text] [Related]
6. Screening for neuroblastoma in children.
Morris J
J Med Screen; 1994 Jul; 1(3):141-2. PubMed ID: 8790505
[No Abstract] [Full Text] [Related]
7. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
Kerbl R; Urban CE; Ladenstein R; Schnellauf C; Sitzwohl C; Lackner H; Gleispach H; Fauler G; Ambros PF; Ambros IM; Rumpler S; Gadner H; Spuller E; Höfler G; Amann G; Kytir J; Mutz I
Wien Klin Wochenschr; 1996; 108(13):398-403. PubMed ID: 8766424
[TBL] [Abstract][Full Text] [Related]
8. Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115000 screened infants in Austria.
Kerbl R; Urban CE; Ambros PF; Lackner H; Ladenstein R; Spuller E; Mutz I; Ambros I; Amann G; Gadner H; Parker L
Eur J Cancer; 1996 Dec; 32A(13):2298-305. PubMed ID: 9038613
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
Kerbl R; Urban CE; Ladenstein R; Ambros IM; Spuller E; Mutz I; Amann G; Kovar H; Gadner H; Ambros PF
Med Pediatr Oncol; 1997 Jul; 29(1):1-10. PubMed ID: 9142198
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma screening: arguments from retrospective analysis of three German neuroblastoma trials.
Berthold F; Hunneman DH; Käser H; Harms D; Bertram U; Erttmann R; Schilling FH; Treuner J; Zieschang J
Am J Pediatr Hematol Oncol; 1991; 13(1):8-13. PubMed ID: 1903028
[TBL] [Abstract][Full Text] [Related]
11. Biochemical screening for neural crest tumors in childhood.
Käser H; Wagner HP
J Pediatr Surg; 1975 Feb; 10(1):69-72. PubMed ID: 1117397
[No Abstract] [Full Text] [Related]
12. Neuroblastoma screening in early life.
Kerbl R; Urban CE; Ambros PF
N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227369
[No Abstract] [Full Text] [Related]
13. Neuroblastoma screening for children: delay, repeat, or delete?
Kerbl R; Urban CE; Ambros IM; Ambros PF
Med Pediatr Oncol; 1998 Aug; 31(2):111-2. PubMed ID: 9680938
[No Abstract] [Full Text] [Related]
14. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of determination of concentrations of catecholamines and their metabolites in the urine of children with neuroblastoma for diagnostic purposes, control of the course and evaluation of the results of therapy].
Prokopczyk J; Wańkowicz B; Wenzel E
Pediatr Pol; 1981 Aug; 56(8):883-8. PubMed ID: 7301482
[No Abstract] [Full Text] [Related]
16. Paediatric reference ranges for urinary catecholamines/metabolites and their relevance in neuroblastoma diagnosis.
Fitzgibbon MC; Tormey WP
Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():1-11. PubMed ID: 8154845
[No Abstract] [Full Text] [Related]
17. The prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplification.
Parodi S; Papio F; Haupt R; Conte M; De Bernardi B
Pediatr Blood Cancer; 2007 May; 48(5):593; author reply 593-4. PubMed ID: 16937359
[No Abstract] [Full Text] [Related]
18. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
19. Natural history of neuroblastoma found by mass screening.
Yamamoto K; Hanada R; Tanimura M; Aihara T; Hayashi Y
Lancet; 1997 Apr; 349(9058):1102. PubMed ID: 9107271
[No Abstract] [Full Text] [Related]
20. Neuroblastoma screening in early life.
Suita S
N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12226161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
